Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea https://t.co/0bdAx9PGGR @Gamma_Monkey #stocks #stockmarket #investing #trading #stockmarketnews #news #stocktrading #Canada #Questrade